(Reuters) - U.S. health regulators approved Takeda Pharmaceutical Co's alogliptin to treat type 2 diabetes as a standalone drug and in two other formulations in combination pills with older diabetes medicines.
via Reuters: Health News Read More Here..
No comments:
Post a Comment